Data / Drug companies / Guangzhou Danting Bath&Body Care Industry Co. Ltd
Guangzhou Danting Bath&Body Care Industry Co. Ltd: 12 products in the FDA NDC directory, labeler code 75376
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guangzhou Danting Bath&Body Care Industry Co. Ltd (labeler code 75376) lists 12 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 12 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 31, 2025.
The request: Watch Guangzhou Danting Bath&Body Care Industry Co. Ltd (FDA labeler code 75376): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 75376
- Products in commercial distribution
- 12
- Packages
- 13
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 12
- Flagged as original packager
- 12 of 12 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 20, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 12 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 12 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Benzoyl peroxide | 4 | 82 |
| Pyrithione zinc | 3 | 76 |
| Ascorbic acid | 1 | 6 |
| Coal tar | 1 | 22 |
| Glycerin, niacinamide | 1 | 1 |
| Avobenzone, homosalate, octisalate, octocrylene | 1 | 157 |
| Dimethicone | 1 | 69 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lotion/shampoo | 4 | 33.3% |
| Cream | 3 | 25% |
| Gel | 3 | 25% |
| Lotion | 2 | 16.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Vitamin C | 1 |
| Non-Standardized Chemical Allergen | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Rugby Benzoyl Peroxide Wash Acne Medication | 75376-474 | Lotion | Over the counter monograph drugs | October 31, 2025 |
| Rugby Benzoyl Peroxide Acne Medication | 75376-459 | Gel | Over the counter monograph drugs | October 31, 2025 |
| Awaken Moisturizing Cream | 75376-104 | Cream | Over the counter monograph drugs | August 21, 2025 |
| Foaming Facial Cleanser | 75376-103 | Cream | Over the counter monograph drugs | June 27, 2025 |
| Skin Renewing Serum | 75376-102 | Cream | Over the counter monograph drugs | June 27, 2025 |
| Sport Ultra | 75376-697 | Lotion | Over the counter monograph drugs | June 17, 2025 |
| Quality Choice Dandruff Dry Scalp Care | 75376-322 | Lotion/shampoo | Over the counter monograph drugs | January 23, 2025 |
| Quality Choice Dandruff 2 in 1 | 75376-321 | Lotion/shampoo | Over the counter monograph drugs | January 23, 2025 |
| Quality Choice Dandruff Everyday Clean | 75376-320 | Lotion/shampoo | Over the counter monograph drugs | January 23, 2025 |
| QC Anti Dandruff T Plus | 75376-286 | Lotion/shampoo | Over the counter monograph drugs | January 17, 2025 |
| Rugby Benzoyl Peroxide Acne Medication | 75376-467 | Gel | Over the counter monograph drugs | January 20, 2015 |
| Rugby Benzoyl Peroxide Acne Medication | 75376-466 | Gel | Over the counter monograph drugs | January 20, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.